Tamoxifen Reduces Breast Cancer Risk in High-Risk American Males: A Long-Term Study
Reading Time: 2 minutesIntroduction Breast cancer, while predominantly affecting women, also poses a significant health risk to men. In the United States, approximately 1% of all breast cancer cases occur in men, highlighting the need for targeted prevention strategies. Tamoxifen, a selective estrogen receptor modulator (SERM), has been extensively studied for its chemopreventive effects in women at high risk for breast cancer. However,... Read more »
